US Patent Issued to CHILDREN'S NATIONAL MEDICAL CENTER on Nov. 25 for "Generating HPV antigen-specific T cells from a naive T cell population" (District Of Columbia Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,478,670, issued on Nov. 25, was assigned to CHILDREN'S NATIONAL MEDICAL CENTER (Washington).

"Generating HPV antigen-specific T cells from a naive T cell population" was invented by Catherine Bollard (Washington), Conrad Cruz (Washington), Patrick Hanley (Washington) and Michael Keller (Washington).

According to the abstract* released by the U.S. Patent & Trademark Office: "Safe, rapid, and efficient methods for producing antigen-specific T cells recognizing human papilloma virus (HPV antigens); HPV-specific T cells, and methods for treating HPV infections and HPV-related malignancies by adoptive transfer of HPV-specific T cells."

The patent was filed on Aug. 17, 2021, under Applica...